Abeona Therapeutics Inc (ABEO.OQ)
ABEO.OQ on NASDAQ Stock Exchange Capital Market
6.38USD
21 Feb 2019
6.38USD
21 Feb 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$6.38
$6.38
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
222,597
222,597
52-wk High
$22.00
$22.00
52-wk Low
$6.28
$6.28
About
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin... (more)
Overall
| Beta: | 2.29 |
| Market Cap(Mil.): | $713.08 |
| Shares Outstanding(Mil.): | 40.29 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ABEO.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.44 | 33.70 |
| EPS (TTM): | -0.60 | -- | -- |
| ROI: | -29.33 | 8.92 | 14.45 |
| ROE: | -30.75 | 10.08 | 15.96 |
Estimates